The retinoblastoma tumor suppressor gene product, pRb, regulates cell cycle progression, and this represents one of its tumor suppressor functions. pRb is also a key participant in a number of differentiation programs; however, there is no compelling genetic or in vivo evidence that pRb's role in the control of cellular differentiation contributes to its tumor suppressor function. Like Rb, the three ras proto-oncogenes regulate differentiation and proliferation. Rb and ras function together to control differentiation in the mouse. Heterozygosity for K-ras or nullizygosity for N-ras (i) rescues many of the developmental defects that characterize Rb-deficient embryos by affecting differentiation, but not proliferation and (ii) significantly enhances the degree of differentiation of pituitary adenocarcinomas arising in Rb heterozygotes, leading to their prolonged survival. Together, these observations suggest that the ability of pRb to affect differentiation is a facet of its tumor suppressor function. Rb+/- mice also develop medullary (C-cell) thyroid adenomas. By contrast, Rb N-ras heterozygotes develop metastatic C-cell carcinomas, with a fraction of these showing loss of the remaining N-ras allele. This counterintuitive observation might be rationalized by the observations that tumors of neuroendocrine origin rarely display mutations in ras and introduction of oncogenic Ras into lines derived from such tumors promotes their differentiation. Research to be conducted examines how loss of N-ras contributes to the development of large primary thyroid tumors and their associated metastases using experimental assays. The possibility that the metastatic behavior of C-cell tumors arising in Rb N-ras mutant animals might be associated with acquisition of the normal migratory and invasive behavior C-cells possess during embryo genesis will be explored. A second line of research will address the requirement for different ras isoforms in transformation. Specifically, the role of K- and N-ras in SV40 T antigen-mediated transformation of murine embryo fibroblasts will be addressed. A third line of investigation is motivated by the observation that skeletal muscle in Rb ras mutant animals continues to display evidence of ongoing proliferation, despite a rescue in differentiation. Detailed research will be focused here on the molecular mechanism by which pRb and the myogenic factor, MyoD, maintain a terminal cell cycle arrest during myogenic differentiation, with emphasis on the regulation of genes known to participate in cell cycle re-entry.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA065842-14
Application #
7433913
Study Section
Cellular Signaling and Dynamics Study Section (CSD)
Program Officer
Spalholz, Barbara A
Project Start
1995-08-10
Project End
2010-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
14
Fiscal Year
2008
Total Cost
$411,467
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Rajabi, Hasan N; Takahashi, Chiaki; Ewen, Mark E (2014) Retinoblastoma protein and MyoD function together to effect the repression of Fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis. J Biol Chem 289:23417-27
Fotiadou, Poppy P; Takahashi, Chiaki; Rajabi, Hasan N et al. (2007) Wild-type NRas and KRas perform distinct functions during transformation. Mol Cell Biol 27:6742-55
Takahashi, Chiaki; Ewen, Mark E (2006) Genetic interaction between Rb and N-ras: differentiation control and metastasis. Cancer Res 66:9345-8
Takahashi, Chiaki; Contreras, Bernardo; Bronson, Roderick T et al. (2004) Genetic interaction between Rb and K-ras in the control of differentiation and tumor suppression. Mol Cell Biol 24:10406-15
Takahashi, Chiaki; Bronson, Roderick T; Socolovsky, Merav et al. (2003) Rb and N-ras function together to control differentiation in the mouse. Mol Cell Biol 23:5256-68
Lamb, Justin; Ramaswamy, Sridhar; Ford, Heide L et al. (2003) A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323-34
Ewen, M E (2000) Relationship between Ras pathways and cell cycle control. Prog Cell Cycle Res 4:17-Jan
Miller, S J; Suthiphongchai, T; Zambetti, G P et al. (2000) p53 binds selectively to the 5' untranslated region of cdk4, an RNA element necessary and sufficient for transforming growth factor beta- and p53-mediated translational inhibition of cdk4. Mol Cell Biol 20:8420-31
McMahon, C; Suthiphongchai, T; DiRenzo, J et al. (1999) P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. Proc Natl Acad Sci U S A 96:5382-7
Lee, K Y; Ladha, M H; McMahon, C et al. (1999) The retinoblastoma protein is linked to the activation of Ras. Mol Cell Biol 19:7724-32

Showing the most recent 10 out of 12 publications